CJ, NKBio sign MOU on stem cell research

Published: 2010-01-11 06:57:00

Updated: 2010-01-11 06:57:00

CJ Corporation and NKBio signed a memorandum of understanding on January 6 to collaborate on joint projects and on the research and development of human amnion-derived mesenchymal stem cells (HAM).

CJ officials expect the MOU to generate synergy in collaboration with a number of stem cell proj...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK